845866-82-2

Basic information

• Product Name: 1-Bromo-2-difluoromethylbenzene
• Synonyms: 1-Bromo-2-(difluoromethyl)benzene, 2-Bromo-alpha,alpha-difluorotoluene;2-Bromobenzal fluoride;2-Bromo-1-(difluoromethyl)benzene
• CAS NO: 845866-82-2
• Molecular Formula: C₇H₅BrF₂
• Molecular Weight: 207.02
• Mol File: 845866-82-2.mol

Chemical Properties

• Boiling Point: 197.2°C at 760 mmHg
• Flash Point: 82℃
• Appearance: Clear colorless/Liquid
• Density: 1.597 g/mL at 25 °C
• Vapor Pressure: 0.539mmHg at 25°C
• Refractive Index: n20/D1.514
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 1-Bromo-2-difluoromethylbenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Bromo-2-difluoromethylbenzene(845866-82-2)
• EPA Substance Registry System: 1-Bromo-2-difluoromethylbenzene(845866-82-2)

Safety Data

• Hazard Codes: Xi,N
• Statements: 36/37/38-51/53
• Safety Statements: 26-61
• HazardClass: IRRITANT
• Hazardous Substances Data: 845866-82-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-Bromo-2-difluoromethylbenzene is used as a key intermediate in the synthesis of pharmaceuticals for its ability to be readily incorporated into complex molecular structures. Its unique combination of bromine and difluoromethyl groups allows for the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 1-Bromo-2-difluoromethylbenzene is employed as a precursor in the production of various agrochemicals, such as pesticides and herbicides. Its reactivity and functional groups enable the creation of compounds that can effectively control and manage pests and weeds in agricultural settings.
Used in Polymer and Material Science:
1-Bromo-2-difluoromethylbenzene is used as a building block in the synthesis of polymers and materials, contributing to the development of advanced materials with specific properties. Its incorporation into polymer structures can enhance characteristics such as thermal stability, chemical resistance, and mechanical strength.
Safety and Handling:
It is crucial to handle and store 1-Bromo-2-difluoromethylbenzene with caution due to its hazardous nature. Proper safety measures should be implemented to minimize health and environmental risks associated with its use. This includes using appropriate personal protective equipment, ensuring proper ventilation, and adhering to storage guidelines to prevent accidental exposure or contamination.

InChI:InChI=1/C7H5BrF2/c8-6-4-2-1-3-5(6)7(9)10/h1-4,7H

Upstream product

• 583-55-1 1-Bromo-2-iodobenzene 
• 6630-33-7 ortho-bromobenzaldehyde 
• 667-27-6 Ethyl bromodifluoroacetate 
• 244205-40-1 (2-bromophenyl)boronic acid 

Downstream Products

• 879275-72-6 2-[2-(difluoromethyl)-phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 1182357-10-3 1-(chloromethyl)-2-(difluoromethyl)benzene 
• 1018678-50-6 2-(difluoromethyl)benzaldehyde 

Relevant articles and documents

Base-Catalyzed H/D Exchange Reaction of Difluoromethylarenes

The budding deuteriodifluoromethyl group (CF2D) is a potentially significant functional group in medicinal chemistry. Herein, we investigated t-BuOK-catalyzed H/D exchange reaction of difluoromethylarenes in DMSO-d6 solution. The method provides excellent

PYRIDAZINONES AND METHODS OF USE THEREOF

Disclosed are compounds according to Formula (A), and related tautomers and pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (A).

SUBSTITUTED BENZOTHIOPHENE ANALOGS AS SELECTIVE ESTROGEN RECEPTOR DEGRADERS

In one aspect, the disclosure relates to relates to substituted benzothiophene analogs which are useful as selective degraders of estrogen receptor, methods of making same, pharmaceutical compositions comprising same, and methods of treating one or more clinical conditions associated with estrogen receptor, such as a cancer, including breast cancer, or osteoporosis. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS

Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

Copper-Catalyzed Difluoromethylation of Aryl Iodides with (Difluoromethyl)zinc Reagent

The combination of difluoroiodomethane and zinc dust or diethylzinc can readily lead to (difluoromethyl)zinc reagents. Therefore, the first copper-catalyzed difluoromethylation of aryl iodides with the zinc reagents is accomplished to afford the difluorom

Access to Difluoromethylated Arenes by Pd-Catalyzed Reaction of Arylboronic Acids with Bromodifluoroacetate

An unprecedented example of Pd-catalyzed difluoromethylation of aryl boronic acids with bromodifluoroacetate is described. The reaction proceeds under mild reaction conditions with hydroquinone and Fe(acac)3 as additives. Preliminary mechanistic studies reveal that a difluorocarbene pathway is involved in the reaction, which is unusual compared to the most traditional approaches. This reaction has advantages of high efficiency and excellent functional group compatibility, even toward bromide and hydroxy group, thus providing a useful protocol for drug discovery and development.

4-Methylsulfonyl-Substituted Piperidine Urea Compounds

The present invention provides novel 4-methylsulphone-substituted piperidine urea compounds that are useful for the treatment of dilated cardiomyopathy (DCM) and conditions associated with left and/or right ventricular systolic dysfunction or systolic reserve. The synthesis and characterization of the compounds is described, as well as methods for treating DCM and other forms of heart disease.

SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS

Provided herein are novel substituted bicyclic aza-heterocycle sirtuin- modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin- modulating compound in combination with another therapeutic agent.

CHROMENONE ANALOGS AS SIRTUIN MODULATORS

Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for e

QUINAZOLINES USEFUL AS MODULATORS OF VOLTAGE GATED ION CHANNELS

The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.